• July 25, 2011
• Defective product

COUMADIN RECALL!! BE AWARE!!

The U.S. Food and Drud Administration has recently RECALLED certain lot numbers with the expiration date of September 30, 2012. The study found that there is a possibility that there may be too much of the active ingredient (which helps to thin the blood for those with histories of blood clots.)

A higher than normal dose of Coumadin may cause stroke, risk of severe internal bleeding, and occasionally, heart attack and death.

If you are experiencing unusual side effects from what you believe to be your normal dose of Coumadin, immediately contact your healthcare professional. If you find that you have received a negligently manufactured dose of Coumadin, please contact us to see if you may qualify for an award for the medical effects you have suffered.